Search for: "Scott v. Eli Lilly and Company" Results 1 - 20 of 20
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
29 Dec 2011, 9:00 pm by Stephanie Figueroa
Armitage of Eli Lilly and Company, and Janet Gongola, Patent Reform Coordinator at the USPTO, helped in breaking down the AIA for the masses. 2) A New Doctrine of Equivalents? [read post]
29 Dec 2011, 9:00 pm by Stephanie Figueroa
Armitage of Eli Lilly and Company, and Janet Gongola, Patent Reform Coordinator at the USPTO, helped in breaking down the AIA for the masses. 2) A New Doctrine of Equivalents? [read post]
5 Jul 2011, 7:07 am by Stefanie Levine
Lambda sued a number of network companies last year for infringement of the '229 patent, including Alcatel-Lucent,NEC, Fujitsu and Nokia-Siemens. [read post]
5 Jul 2011, 7:07 am by Stefanie Levine
Lambda sued a number of network companies last year for infringement of the '229 patent, including Alcatel-Lucent,NEC, Fujitsu and Nokia-Siemens. [read post]
5 Jul 2020, 5:43 am by Annsley Merelle Ward
  On a recent celebratory birthday call, members of IP Federation (which today include BT, Dyson, GSK, Pfizer, Ocado, Arm, Microsoft, IBM, Rolls-Royce, Shell, Merck Sharp & Dohme,  Ford and Eli Lilly) shared memories of their work, triumphs and tribulations. [read post]
19 Feb 2012, 4:21 pm by Lawrence B. Ebert
Eli Lilly wrote in an email that antidepressants work. [read post]
3 Dec 2009, 12:13 am
Federal Judge Knocks Out Most of Mississippi's Zyprexa Case Against Eli Lilly The American Lawyer Mississippi Attorney General Jim Hood's aggressive posture against Eli Lilly in a case involving the controversial anti-psychotic Zyprexa hasn't paid off. [read post]
19 Sep 2013, 9:53 am by Bexis
  By itself, off-label promotion is no more causal than, as we commented the other day, a “video of a company employee kicking his dog. [read post]
20 May 2012, 1:11 pm
 On the face of it, Plavix's patent expiry may have arguably paved the way for Eli Lilly & Co's and AstraZeneca's own blood-thinning drugs, Effient and Brilinta respectively, to gain more market share but the expiry of the patent does not mean that increasing the market share of their competitor drugs will be easy. [read post]
5 Feb 2012, 5:01 pm by Lawrence Higgins
Eli Lilly's profit dropped 27% because of Zyprexa going generic. [read post]
9 Aug 2008, 1:50 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: The end of William Patry’s blog: (Patry Copyright Blog), (Excess Copyright), (Patently-O), (Chicago IP Litigation Blog), (Michael Geist), (The Fire of Genius), (Techdirt), (Patry Copyright Blog), Kitchin J clarifies scope of biotech patents, in particular gene sequence patents: Eli Lilly & Co v Human… [read post]
30 May 2008, 9:09 am
: (Spicy IP), India: DCGI preparing document to implement patent-registration linkage: (Spicy IP), New Zealand: Generic pharmaceutical companies taking advantage of NZ IP laws and medicines regulations: (International Law Office), Uganda: Cipla licenses ARV technology into Uganda: (Afro-IP), US: Money saved through generic prescriptions: (GenericsWeb), US: Government plans to keep close tab on drug patent settlements: (GenericsWeb), US: FTC reports 14 deals to delay generics in 2007:… [read post]
29 Aug 2008, 1:25 pm
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: CAFC sets strict standards to establish inequitable conduct: Star Scientific v R J Reynolds Tobacco: (Hal Wegner), (Maryland Intellectual Property Law Blog), (Patent Prospector), (Patent Docs), (Patently-O), (more from Patently-O), (Philip Brooks), (Law360), (I/P Updates), Safe harbour ruling in Io v Veoh could help YouTube in Viacom… [read post]
16 Mar 2011, 3:25 pm by Rebecca Tushnet
We analyzed 120 companies: food/beverage, entertainment, etc. [read post]
21 Jan 2007, 5:42 pm
(Joe Scott Miller's running web page tally of post-eBay cases shows this. [read post]
22 Mar 2008, 2:00 am
: (IPBiz),US: Two remaining challenged WARF embryonic stem cell patents upheld in ex parte reexamination: (Holman's Biotech IP Blog), Pharma & Biotech - ProductsAricept (Donepezil) – USV wins appeal against USPTO decision: (Spicy IP),Celerex (Celecoxib) – CAFC decision in Celebrex patents dispute between Pfizer and Teva will cut patent term by one and a half years: (Patent Baristas), Inersan – Ranbaxy in-licenses Inersan to CD Pharma to market in India and… [read post]